Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMM

Immupharma (IMM)

Immupharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:IMM
DateTimeSourceHeadlineSymbolCompany
12/22/20224:09PMAlliance NewsAlliance NewsTRADING UPDATES: Ground Rents Income Fund's portfolio value dropsLSE:IMMImmupharma Plc
12/22/20222:55AMUK RegulatoryImmupharma PLC Grant of OptionsLSE:IMMImmupharma Plc
12/22/20222:00AMUK RegulatoryImmupharma PLC End of Year UpdateLSE:IMMImmupharma Plc
11/23/20222:44AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
11/14/202211:40AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
11/14/202211:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
11/11/20222:56PMAlliance NewsAlliance NewsTRADING UPDATES: Driver records loss; Synectics sells business unitLSE:IMMImmupharma Plc
11/11/20224:00AMDow Jones NewsImmuPharma, Avion Agree to Continue Lupus Program; Explore Distribution AgreementLSE:IMMImmupharma Plc
11/11/20222:31AMUK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
10/11/202211:40AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
10/11/202211:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
10/07/202211:44AMUK RegulatoryImmupharma PLC Company Secretary ChangeLSE:IMMImmupharma Plc
10/06/20223:10PMAlliance NewsAlliance NewsTRADING UPDATES: ImmuPharma loss narrows; MetalNRG loss widensLSE:IMMImmupharma Plc
10/06/202212:17PMUK RegulatoryIncanthera PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
09/30/20222:30AMUK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
09/30/20222:00AMUK RegulatoryImmupharma PLC Interim Results or the 6mths Ended 30 June 2022LSE:IMMImmupharma Plc
09/29/202211:40AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
09/29/202211:37AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
09/14/20227:46AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma receives response for FDA for LupuzorLSE:IMMImmupharma Plc
09/14/20226:06AMDow Jones NewsImmuPharma Shares Fall on FDA's Lupuzor Treatment ResponseLSE:IMMImmupharma Plc
09/14/20225:04AMUK RegulatoryImmupharma PLC Written Response received from the FDALSE:IMMImmupharma Plc
09/07/20224:55AMAlliance NewsAlliance NewsImmuPharma raises GBP150,000 via issue of 3 million new sharesLSE:IMMImmupharma Plc
09/07/20223:25AMUK RegulatoryImmupharma PLC Exercise of OptionsLSE:IMMImmupharma Plc
08/31/20224:41PMAlliance NewsAlliance NewsTRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on auditLSE:IMMImmupharma Plc
08/31/20223:05AMDow Jones NewsImmuPharma Says US Partner Hasn't Had Written Response From FDA Over LupuzorLSE:IMMImmupharma Plc
08/31/20222:01AMUK RegulatoryImmupharma PLC FDA response for Type C Meeting - updateLSE:IMMImmupharma Plc
08/30/20226:29AMUK RegulatoryImmupharma PLC Exercise of OptionsLSE:IMMImmupharma Plc
08/24/20223:11AMUK RegulatoryImmupharma PLC Exercise of OptionsLSE:IMMImmupharma Plc
08/17/20221:12PMUK RegulatoryImmupharma PLC TR-1 Notification of major holdingsLSE:IMMImmupharma Plc
08/16/20223:03AMUK RegulatoryImmupharma PLC Total Voting RightsLSE:IMMImmupharma Plc
 Showing the most relevant articles for your search:LSE:IMM